Skip to main content
Clinical Trials/EUCTR2009-013403-55-NL
EUCTR2009-013403-55-NL
Active, not recruiting
Not Applicable

Early recognition and optimal treatment of delirium in patients with advanced cancer. - RCT Delirium in cancer patients

VU university medical center0 sitesJuly 9, 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Delirium in patients with advanced cancer
Sponsor
VU university medical center
Status
Active, not recruiting
Last Updated
13 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 9, 2009
End Date
TBD
Last Updated
13 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
VU university medical center

Eligibility Criteria

Inclusion Criteria

  • Patient has been diagnosed with advanced cancer;
  • Age \= 18;
  • Patient or his / her significant other speaks Dutch fluently.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 100
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 100

Exclusion Criteria

  • Delirium is due to alcohol withdrawal;
  • Patient has been diagnosed with glaucoma, Parkinson’s disease or dementia;
  • Patient is being treated with other neuroleptic medication or lithium (except for low dose neuroleptics used in the treatment of neuropathic pain;
  • Patient has another psychiatric disorder that is considered (by investigator) to interfere withassessment of delirium;
  • Patient had a QTc\-interval of \> 480 msec on ECG made on admission;
  • Patient has a history of neuroleptic malignant syndrome;
  • Patient has a history of convulsions.

Outcomes

Primary Outcomes

Not specified

Similar Trials